A phase III trial of Epidiolex in patients with infantile spasms
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Cannabidiol (Primary)
- Indications Infantile spasms
- Focus Registrational; Therapeutic Use
- Sponsors GW Pharmaceuticals
- 05 Dec 2016 Status changed from planning to recruiting, according to a GW Pharmaceuticals media release.
- 24 Jun 2016 New trial record
- 21 Jun 2016 According to a GW Pharmaceuticals media release, this trial is expected to initiate in the fourth quarter of 2016.